These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31270134)

  • 1. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.
    Kruthika BS; Sugur H; Nandaki K; Arimappamagan A; Paturu K; Santosh V
    J Clin Pathol; 2019 Oct; 72(10):677-681. PubMed ID: 31270134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma.
    Kruthika BS; Jain R; Arivazhagan A; Bharath RD; Yasha TC; Kondaiah P; Santosh V
    J Neurooncol; 2019 Jan; 141(2):315-325. PubMed ID: 30460633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma.
    Wang JH; Zhang L; Huang ST; Xu J; Zhou Y; Yu XJ; Luo RZ; Wen ZS; Jia WH; Zheng M
    PLoS One; 2017; 12(4):e0175280. PubMed ID: 28388691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
    Han J; Puri RK
    J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
    Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
    J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3K27M, IDH1, and ATRX expression in pediatric GBM and their clinical and prognostic significance.
    Uppar AM; Sugur H; Prabhuraj AR; Rao MB; Devi BI; Sampath S; Arivazhagan A; Santosh V
    Childs Nerv Syst; 2019 Sep; 35(9):1537-1545. PubMed ID: 31152217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
    Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G
    J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of EGFR in Paired New and Recurrent Glioblastomas.
    Cioca A; Olteanu EG; Gisca MD; Morosanu CO; Marin I; Florian IS
    Asian Pac J Cancer Prev; 2016; 17(9):4205-4208. PubMed ID: 27797218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.
    Deng Y; Liu L; Feng W; Lin Z; Ning Y; Luo X
    Recent Pat Anticancer Drug Discov; 2021; 16(4):533-539. PubMed ID: 34551701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival.
    Chaurasia A; Park SH; Seo JW; Park CK
    J Korean Med Sci; 2016 Aug; 31(8):1208-14. PubMed ID: 27478330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
    Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D
    Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
    Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL
    PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
    Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
    J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 expression and prognostic impact in glioblastoma.
    Nduom EK; Wei J; Yaghi NK; Huang N; Kong LY; Gabrusiewicz K; Ling X; Zhou S; Ivan C; Chen JQ; Burks JK; Fuller GN; Calin GA; Conrad CA; Creasy C; Ritthipichai K; Radvanyi L; Heimberger AB
    Neuro Oncol; 2016 Feb; 18(2):195-205. PubMed ID: 26323609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma.
    Matsushita K; Kobayashi S; Akita H; Konno M; Asai A; Noda T; Iwagami Y; Asaoka T; Gotoh K; Mori M; Doki Y; Eguchi H; Ishii H
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1582. PubMed ID: 34821071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival kinase genes present prognostic significance in glioblastoma.
    Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
    Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
    Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
    J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.